Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Health Fund

+ Add to Watchlist

AXAHLZA:LN

212.90 GBp 0.50 0.24%

As of 00:59:30 ET on 03/27/2015.

Snapshot for AXA Framlington Health Fund (AXAHLZA)

Year To Date: +13.06% 3-Month: +13.85% 3-Year: - 52-Week Range: 141.87 - 220.40
1-Month: +4.36% 1-Year: +41.96% 5-Year: - Beta vs FTWBWRLD: 0.94

Mutual Fund Chart for AXAHLZA

No chart data available.
  • AXAHLZA:LN 212.90
  • 1M
  • 1Y
Interactive AXAHLZA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AXAHLZA

AXA Framlington Health Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to achieve capital growth. It invests in producers of pharmaceuticals, bio-technology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies along ethical guidelines.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: MARK HARGRAVES / LINDEN THOMSON
Web Site: www.axa-framlington.com

Fundamentals for AXAHLZA

NAV (on 2015-03-27) 212.90
Assets (M) (on 2015-01-30) 511.60
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for AXAHLZA

Dividend Type Accumulation
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-11-03) 0.24
Dividend Yield (ttm) 0.12

Fees & Expenses for AXAHLZA

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for AXAHLZA

Filing Date: 02/27/2015
Name Position Value % of Total
Roche Holding AG 165,617 28,236,600 5.400%
Gilead Sciences Inc 389,915 26,145,000 5.000%
Novartis AG 364,940 23,530,500 4.500%
Amgen Inc 204,757 20,916,000 4.000%
AbbVie Inc 467,066 18,301,500 3.500%
Biogen Inc 68,990 18,301,500 3.500%
Medtronic PLC 291,352 14,641,200 2.800%
Celgene Corp 172,725 13,595,400 2.600%
UnitedHealth Group Inc 178,223 13,072,500 2.500%
Express Scripts Holding Co 199,959 10,980,900 2.100%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil